Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Published:2021-10 Issue:14 Volume:78 Page:1393-1403
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Chin Kelly M.,Sitbon Olivier,Doelberg Martin,Feldman Jeremy,Gibbs J. Simon R.,Grünig Ekkehard,Hoeper Marius M.,Martin Nicolas,Mathai Stephen C.,McLaughlin Vallerie V.,Perchenet Loïc,Poch David,Saggar Rajan,Simonneau Gérald,Galiè Nazzareno

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled;Hemnes;Eur Respir Rev,2017

2. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives;Humbert;Eur Respir J,2019

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

4. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

5. Risk stratification and medical therapy of pulmonary arterial hypertension;Galiè;Eur Respir J,2019

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Eisenmenger syndrome – Review of pathophysiology and recent progress in risk assessment and management;International Journal of Cardiology Congenital Heart Disease;2024-09

2. Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

5. Mechanisms and treatment of pulmonary arterial hypertension;Nature Reviews Cardiology;2024-08-07